Pathogenetic therapeutic and preventive measures in women of risk group of isthmicocervical incompetence

Authors

DOI:

https://doi.org/10.18370/2309-4117.2017.36.44-47

Keywords:

isthmicocervical incompetence, magnesium deficiency, connective tissue dysplasia

Abstract

The article considers the problem of isthmicocervical incompetence (ICI) as one of the leading factors in the genesis of premature termination of pregnancy. As noted, the frequency of this pathology in the population among pregnant women reaches 15%. The results of the study are presented, the purpose of which was to study the clinical effectiveness of the use of the drug Biolectra Magnesium Fortissimum in preconception prevention of ICI in women with undifferentiated connective tissue dysplasia on the background of a magnesium deficiency.

The study involved 50 women at risk of ICI (hypomagnesemia, decrease in the index of resistance in the small arteries of cervix uteri (CU), ultrasound signs of connective tissue dysplasia). The age of women ranged from 20 to 40 years. Most subjects had clinical symptoms of magnesium deficiency: tachycardia occurred in 28%, sleep disorders in 24%, general fatigue in 20%, constipation in 18%, paresthesia in 36%, muscle spasms in 18% of cases.

The mean magnesium concentration in the blood plasma of the patients was 0.74 ± 0.03 mmol/l. The conducted studies showed a significant decrease in the index of resistance in small arteries of CU in 86% of women, which indicated the presence of morphofunctional deficiency of CU. Also, in 78% of women, echographic examination revealed the presence of collagenopathy.

To correct the magnesium deficiency in the pregestation period, women were prescribed the drug Biolectra Magnesium Fortissimum (Hermes Arzneimittel GmbH, Germany) for 1 effervescent tablet once a day for 10 days with a break of 2 weeks for 3–4 months. After completion of the course of treatment, in most cases there was a lack or decrease in the frequency and intensity of symptoms of magnesium deficiency symptoms. The gradient of magnesium level increase after a 3-month therapy was 0.14 ± 0.03 mmol/l. Residual phenomena of paresthesia occurred only in 10% of women, muscle cramps – in 8%. In 60% of women, there was an approximation of the blood flow resistance in the small arteries of CU (RI 0.63 ± 0.03) and in 64% of cases the ultrasonic examination of CU revealed an increase in the reflectivity of the organ, which indicating stabilization of collagen structures, changes in the morphofunctional state of CU, normalization of hemodynamic processes in the organ.

Thus, the use of drug Biolectra Magnesium Fortissimum in magnesium deficiency provided an effective correction of hypomagnesemia, positively influenced the morphofunctional state of CU, which helped prevent the complication of pregnancy in 80% of cases.

Author Biographies

Л. Б. Маркін, Danylo Halytsky Lviv National Medical University

MD, professor, corresponding member of the NAMS of Ukraine, head of the Obstetrics and Gynecology Department

Т. Ф Татарчук, SI “Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”

MD, professor, corresponding member of the NAMS of Ukraine, deputy director for research work, head of the Endocrine Gynecology Department

К. Л. Шатилович, Danylo Halytsky Lviv National Medical University

MD, associate professor at the Obstetrics and Gynecology Department

References

  1. Zaporozhan, V.M., Tsehelskyi, M.R., Rozhkovska, N.M. Obstetrics and gynecology. Tutorial: in 2 volumes. Vol. 1. Odesa. Odesa State Medical University (2008): 472 p.
  2. Sidorova, I.S., Kulakov, V.I., Makarov, I.O. Tutorial in obstetrics. Moscow. Medicine (2006): P. 331–5.
  3. Robboy, S. Pathology of the Female Reproductive Truct. Churchill Livingstone (2002): 929.
  4. Dubossarska, Z.M. “Modern view on etiopathogenesis, diagnosis and treatment of miscarriages.” Medical aspects of woman’s health 6.7 (2012): 12–16.
  5. Barth, W.H. “Cervical incompetence and cerclage: unresolved contraversies.” Clyn Obstet Gynecol 34.4 (1994): 831–41.
  6. Nazarenko, L.G., Khani, R.I. “Forecasting of cervical insufficiency and loss of pregnancy in the second trimester.” Achievements of clinical and experimental medicine 1 (2010): 96–9.
  7. Golianovskyi, O.V., Mekhedko, V.V., Galich, I.D. “Isthmicocervical incompetence: modern methods of correction.” Woman’s doctor 2 (2012): 39–45.
  8. Gromova, O.A. “Molecular mechanisms of magnesium action on connective tissue dysplasia.” Journal for practicing doctors 1 (2008): 23–32.
  9. Kadurina, T.I., Gorbunova, V.N. Dysplasia of connective tissue. St. Petersburg (2009): 701 p.
  10. Kokh, L.I., Satysheva, I.V. “Diagnosis and results of treatment of isthmicocervical incompetence.” Obstetrics and Gynecology 7.2 (2011): 29–32.
  11. Markin, L.B., Prokip, U.E. “Correction of magnesium deficit in pregnant women with isthmicocervical incompetence.” Clinical pharmacy, pharmacotherapy and medical standardization 3–4.20–21 (2013): 78–81.
  12. Markin, L.B., Prokip, U.E. “Prophylactic and therapeutic measures for idiopathic isthmicocervical incompetence.” Health of a woman 10.96 (2014): 61–4.
  13. Patent for useful model № 96950 Ukraine, IPC (2006.1) A61V 8/08. Method of diagnosing connective tissue dysplasia in the cervix uteri / Markin, L.B., Prokip, U.E.; applicant and patentee Danylo Halytsky Lviv National Medical University, No. u 2014 10064; appl. 15.09.2014; publ. 25.02.2015, Bull. Number 8.
  14. Starostina, Т.А., Lipman, A.D., Cheremnykh, A.Y. “Diagnostic value of blood flow parameters in the uterine arteries and small arteries of the cervix uteri in case of isthmicocervical incompetence.” Obstetrics and Gynecology 2 (1998): 5–17.
  15. Markin, L.B., Prokip, U.E. “Influence of correction of hypomagnesaemia on gestational process during isthmicocervical incompetence.” International Journal of Pediatrics, Obstetrics and Gynecology 7.3 (2015): 63–4.
  16. Markin, L.B., Popovych, A.I., Prokip, U.E. “Correction of native magnesium deficiency in the precognitive period.” Actual problems of pediatrics, obstetrics and gynecology 1 (2015): 155–7.
  17. Gryaznov, D.A., Melnik, M.V., Osia, A.O. “The role of magnesium deficiency in the pathogenesis of metabolic syndrome.” Russian Medical Journal 16.21 (2008): 23–8.
  18. Fofanova, I.Y. “Magnesium deficiency and its relations with obstetric practice.” Medical advice 5 (2013): 31–36.

Downloads

Published

2017-09-14

How to Cite

Маркін, Л. Б., Татарчук, Т. Ф., & Шатилович, К. Л. (2017). Pathogenetic therapeutic and preventive measures in women of risk group of isthmicocervical incompetence. REPRODUCTIVE ENDOCRINOLOGY, (36), 44–47. https://doi.org/10.18370/2309-4117.2017.36.44-47

Issue

No. 36 (2017)

Section

Clinical study

License

Copyright (c) 2017 Л. Б. Маркін, Т. Ф Татарчук, К. Л. Шатилович

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.